Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/27/12 | 8-K | Current report filing |
|
3 | |
| 09/21/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/14/12 | 8-K | Current report filing |
|
4 | |
| 09/05/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/05/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/05/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/05/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/05/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/05/12 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act |
|
6 | |
| 08/22/12 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
   |
76 |
